Entries by melindaroberts

12th Annual Lundberg Institute Lecture: How to Decide Which Medical and Health Information You Should Trust

Get tickets here! Fake news? Alternative facts? Overly hyped “breakthroughs”? Irreproducible scientific research results? Preprints? Gaslighting the medical literature? What to do? Finding and trusting the best published primary medical literature is the answer. Our speakers for the 12th Annual Lundberg Institute Lecture at The Commonwealth Club, JAMA Editor in Chief Kirsten Bibbins-Domingo and BMJ Editor in Chief Kamran Abbasi, […]

How an Expert Would Manage His Own Advanced Prostate Cancer

When facing a new cancer diagnosis, some people ask their doctors, “What would you do if you were me?” Here, our Curious Dr. George asks Marc B. Garnick, MD, how he would handle his own advanced prostate cancer. Dr. Garnick is the Gorman Brothers Professor of Medicine at Harvard Medical School (HMS) and Beth Israel […]

Harnessing Each Patient’s Data to Help Many More

At Cancer Commons, we don’t just help people navigate cancer treatment; we learn from everyone we help. Here, our Curious Dr. George asks Cancer Commons Clinical Scientist Kaumudi Bhawe, PhD, to share how new knowledge can be captured from every patient to help many more. Curious Dr. George: Cancer Commons has accumulated in-depth data on many […]

Plain Language Summaries Improve Access to Medical Research

Cancer Commons helps people make sense of the latest research on treatments for their distinct type of cancer. Meanwhile, a growing number of research papers now include a plain language summary (PLS)—an overview of the paper written for anybody to understand. Here, our Curious Dr. George discusses plain language summaries with Adeline Rosenberg, MSc, Senior […]

Can Immunotherapy Be Effective for Brain Cancer?

Immunotherapy has reshaped the cancer treatment landscape. This type of treatment boosts the immune system to fight cancer. However, for people with advanced brain cancer, immunotherapy options remain slim. Here, our Curious Dr. George asks Cancer Commons Scientist Matt Warner, PhD, about the challenges and future potential of immunotherapy for brain cancer. Curious Dr. George: An accomplished […]

Cancer Commons Adapts to Remain True to Our Mission

People facing advanced cancer come to Cancer Commons to ensure they have all the information they need to make their best-possible cancer care decisions. Here, Curious Dr. George asks our CFO & COO Shelley Frisbie about recent updates to our organization. Curious Dr. George: You have been the CFO of Cancer Commons for some time and […]

Cellular Aging and the Development of Cancer

Cancer is so often a disease of older people that a whole medical field, “oncogeriatrics,” exists to address the topic. Deeper understanding of the links between cancer and aging could lead to better treatments. Here, our Curious Dr. George asks Cancer Commons Clinical Scientist Kaumudi Bhawe, PhD, about the relationship between cancer and aging processes […]

More Information from Less Tissue: Strata Oncology Excels

  For a growing number of advanced cancer patients, molecular testing of tumor tissue is an essential step in identifying their best options for treatment. Strata Oncology is one company offering this kind of test. Here, our Curious Dr. George asks two of its leaders what sets Strata apart. Curious Dr. George: No loop is stronger than its […]